The P.E.R.I.E. process’s the recommendation component determines the best course of action based on the evidence to improve health outcomes. It usually considers both the safety and efficacy of the interventions, besides the quality of evidence. In the early and mid-20th Century, there was minimal recognition of the dangers of hypertension. Intervention such as, rice diet by Walter Kempner and inducing high fevers could prolong life and lower B.P. among high blood pressure patients. Whereas the evidence quality showed a reduction in B.P., the treatments were unsuccessful in the long term and subjected patients to strenuous lifestyles Roccella, 2018). However, the recommendations of N.H.B.P.E.P. launched by the National Institutes of Health have been the most significant intervention (Roccella, 2018). It recommended creating awareness about the relationship between high blood pressure, heart disease, and stroke.
The P.E.R.I.E. process’s implementation phase involves putting the actions the best recommendations through various. Over the years, multiple interventions for high blood pressure have been implemented in the United States. The N.H.P.E.P.’s recommendation to increase awareness provides critical insight into the implementation component. The implementation process used available evidence from studies and racial and regional disparities in hypertension control (Roccella, & Lenfant, 1989). The united states prefer educational strategies. Hence, it adopted the use of mass media communication, community screening, and educational interventions.
Evaluation as the last stage of the P.E.R.I.E. process identifies the effectiveness of an intervention in reducing the identified problem. Using the RE-AIM framework, evaluation determines the integration of the intervention into public health practice. Most interventions by U.S. public health targeted changes of lifestyle to slow down or prevent high blood pressure that comes with aging (Hyseni et al., 2017). Using RE-AIM, the effectiveness of these interventions can be determined using data on the high B.P., stroke, and heart disease. The prevalence rate of hypertension is around 30% and 83% awareness in the united states (Saklayen & Deshpande, 2016). However, stroke and heart disease are the third and first causes of the United States, despite a reduction in the deaths from cardiovascular disease.
References
Hyseni, L., Elliot-Green, A., Lloyd-Williams, F., Kypridemos, C., O’Flaherty, M., McGill, R., … & Capewell, S. (2017). Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?. PloS one, 12(5), e0177535.
Riegelman, R. K. (2020). Studying a study and testing a test. Lippincott Williams & Wilkins.
Roccella, E. (2018). Treating Hypertension: A Public Health Success Story | The Pursuit | University of Michigan School of Public Health | Chronic Disease | Disability | Exercise | Obesity | Heart Disease | Pharmaceuticals. Sph.umich.edu. Retrieved 2 May 2021, from https://sph.umich.edu/pursuit/2018posts/treating-hypertension.html.
Roccella, E. J., & Lenfant, C. (1989). Regional and racial differences among stroke victims in the United States. Clinical Cardiology, 12(S4), IV-18.
Saklayen, M. G., & Deshpande, N. V. (2016). Timeline of the history of hypertension treatment. Frontiers in cardiovascular medicine, 3, 3.
